The post contains 50 new customer stories, which appear at the beginning of each section of customer lists. The post will be ...

Just a heads up, if you buy something through our links, we may get a small share of the sale. It’s one of the ways we keep ...

Separately, Rakovina Therapeutics expects to receive the first synthesized drug candidates from its second AI-driven drug discovery program targeting ATR.

Evercore ISI analyst Mark Lipacis maintained a Buy rating on Texas Instruments (TXN – Research Report) yesterday and set a price target of ...